Independent reference. Not affiliated with, endorsed by, or speaking for the U.S. Food and Drug Administration.
FDA Medication Tracker

← All approvals · Weight loss & diabetes · 2026

Awiqli (insulin icodec-abae)

The FDA approved Awiqli (insulin icodec-abae) on March 26, 2026 to improve glycemic control in adults with type 2 diabetes mellitus.
Brand name
Awiqli
Generic name
insulin icodec-abae
FDA approval date
March 26, 2026
Approved use (FDA wording)
To improve glycemic control in adults with type 2 diabetes mellitus
Category on this site
Weight loss & diabetes

Official sources

Facts only. This site lists what the FDA has approved and what the FDA says each drug is approved for, quoted or closely paraphrased from FDA and openFDA records. It gives no medical advice, no dosing, and no comparisons, and it says nothing about whether a drug is right for anyone. Talk to a licensed clinician about any medication. Records can lag or contain errors; the FDA's own pages are authoritative.